Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial
Lucas Otieno(United States Army Medical Research Directorate - Africa), Mary J. Hamel(World Health Organization)
Cited by 34
Related Papers
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451